Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New NPS compounds interact with a novel site on receptor-operated Ca2+ channels

May 11, 2000

Another neuropharmaceutical patent filing announced by IGT

May 10, 2000

Ares-Serono exercises license option to antiamyloid technology

May 9, 2000

New dopaminergic agents from Neurogen for neuropsychological disorders

May 9, 2000

AAN news: trial determines doses of Antegren for multiple-dose studies in MS

May 8, 2000

BMS-204352: a novel maxi-K channel opener effective in rat models of acute focal stroke

May 8, 2000

5-HT1D receptor-selective diazabicyclooctanes designed at Merck

May 8, 2000

No consistent cognitive or motor effects detected for SIB-1508Y in safety study in early PD

May 5, 2000

Novel antiinflammatory drug tested in Sweden for efficacy in Alzheimer's disease

May 5, 2000

Clinical development of Neotrofin for AD reviewed at recent symposium

May 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...